OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth

Document Sample
OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth Powered By Docstoc
					OTC Pharmaceuticals and Self-medication in Seven
Emerging Markets
Expanded Access, Aging Populations and Increasing Obesity Levels to Drive
Future Growth
GBI Research Report Guidance




                                              GBI Research Report Guidance
                                              The report features the seven emerging markets of China, India, Russia, Brazil, Mexico, Turkey and
                                              Indonesia and provides OTC market forecasts to 2018 and market segmentation in terms of product
                                              category.
                                              ·     Chapter three gives information on OTC regulations in each market.
                                              ·     Chapter four defines and describes the main OTC product categories.
                                              ·     Chapter five compares the OTC sales and growth rates for the seven regions in 2011-2018 and analyzes
                                                    the important drivers and barriers for the industry.
                                              ·     Chapter six details, for each market, how living conditions, health expectations, local healthcare
                                                    systems and socioeconomic factors can be used to explain and predict trends in OTC sales.
                                              ·     Chapter seven looks at some of the major trends that are likely to shape the future OTC landscape in
                                                    the seven featured markets.




  © GBI Research. This is a licensed product and is not to be photocopied                                                 GBIHC253MR / Published NOV 2012
                                                                                                                                                   Page 2
OTC Pharmaceuticals and Self-medication in Seven Emerging Markets -
Executive Summary




                                              OTC Pharmaceuticals and Self-medication in Seven Emerging Markets -
                                              Executive Summary
                                              Emerging Markets Represent Opportunities for Growth in the OTC Pharmaceutical Market
      Those Aged over 60 use the              This report covers the Over-The-Counter (OTC) markets in China, India, Russia, Brazil, Mexico, Indonesia and
      Most OTC Products,                      Turkey. All are expected to continue growth trends over the 2011-2018 period, with Russia experiencing the
      Worldwide, of Any Age                   fastest growth at a Compound Annual Growth Rate (CAGR) of 12.4%.
      Group
                                               OTC Market, Seven Emerging Markets, Sales ($bn), 2011-2018

                                                                     60

                                                                                 CAGR 2011–2018: 9.5%

                                                                     50




                                                                     40
                                                     Revenue ($bn)




                                                                     30




                                                                     20




                                                                     10




                                                                      0
                                                                          2011         2012        2013   2014   2015   2016       2017       2018


                                               Source: GBI Research



                                              Over the 2011-2018 period the combined seven emerging markets are expected to grow at a CAGR of 9.5%
                                              from $28 billion to $53 billion. Consumers within these markets are becoming more affluent and better-
                                              informed in terms of health education, leading to an increase in self-care and in the purchase of OTC
                                              pharmaceuticals.
                                              Significant Growth within Six Product Categories
                                              The report covers six main product categories:
                                              ·     Cough, cold and allergy treatments
                                              ·     Analgesics and antipyretics
                                              ·     Gastrointestinal remedies
                                              ·     Dermatological products
                                              ·     Vitamins, minerals and supplements
                                              ·     Lifestyle OTC products
                                              The success of each of these product categories is highly dependent upon the circumstances of consumers
                                              within each market. For example, those that live in more crowded areas are more likely to catch coughs and
                                              colds, leading to a better market for the corresponding category.




  © GBI Research. This is a licensed product and is not to be photocopied                                                      GBIHC253MR / Published NOV 2012
                                                                                                                                                        Page 3
OTC Pharmaceuticals and Self-medication in Seven Emerging Markets -
Executive Summary




                                              Rising Obesity Levels and Aging Populations are Significant Growth Factors
                                              All seven markets have aging populations due to improved healthcare systems and better general living
                                              conditions. This is a significant driver for the OTC market as those aged over 60 use the most OTC products,
                                              worldwide, of any age group (EBM, 2012). Obesity is also increasing within these markets, particularly in
                                              China. This will drive the growth of the overall OTC market and will act as a specific driver for weight
                                              management products, which fall into the lifestyle OTC category.




  © GBI Research. This is a licensed product and is not to be photocopied                                                  GBIHC253MR / Published NOV 2012
                                                                                                                                                    Page 4
Table of Contents




                                              1         Table of Contents
                                              1   Table of Contents ........................................................................................................................................ 5
                                                  1.1      List of Tables .................................................................................................................................... 7
                                                  1.2      List of Figures................................................................................................................................... 7
                                              2   Introduction ................................................................................................................................................ 9
                                              3   OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Overview ................................. 10
                                                  3.1      Overview ....................................................................................................................................... 10
                                                  3.2      OTC Pharmaceuticals ..................................................................................................................... 10
                                                  3.3      Rx-to-OTC Switching ...................................................................................................................... 10
                                                  3.4      Regulation of OTC Pharmaceuticals .............................................................................................. 11
                                                      3.4.1      China ..................................................................................................................................... 11
                                                      3.4.2      India ...................................................................................................................................... 12
                                                      3.4.3      Russia .................................................................................................................................... 12
                                                      3.4.4      Brazil ..................................................................................................................................... 13
                                                      3.4.5      Mexico ................................................................................................................................... 13
                                                      3.4.6      Turkey.................................................................................................................................... 14
                                                      3.4.7      Indonesia ............................................................................................................................... 14
                                              4   OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Product Types ......................... 15
                                                  4.1      OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Overview ..................... 15
                                                  4.2      Leading Product Types .................................................................................................................. 15
                                                      4.2.1      Cough, Cold and Allergy ........................................................................................................ 15
                                                      4.2.2      Analgesics/Antipyretics ......................................................................................................... 15
                                                      4.2.3      Gastrointestinal ..................................................................................................................... 16
                                                      4.2.4      Dermatologicals .................................................................................................................... 16
                                                      4.2.5      Vitamins, Minerals and Supplements .................................................................................... 17
                                                      4.2.6      Lifestyle OTC Products ........................................................................................................... 17
                                              5   OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Comparison............................. 18
                                                  5.1      OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, 2011-2018 ................... 18
                                                  5.2      OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Market Drivers and
                                                           Restraints ...................................................................................................................................... 20
                                                  5.3      OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, Forecast Methodology . 22
                                              6   OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Geographical Breakdown........ 23
                                                  6.1      China.............................................................................................................................................. 23
                                                      6.1.1      Introduction ........................................................................................................................... 23
                                                      6.1.2      OTC Category Analysis........................................................................................................... 30
                                                      6.1.3      Key Growth Drivers and Restraints ........................................................................................ 32
                                                      6.1.4      OTC Sales Forecast to 2018 ................................................................................................... 33
                                                      6.1.5      Recent Developments ............................................................................................................ 34
                                                      6.1.6      Outlook .................................................................................................................................. 34
                                                  6.2      India ............................................................................................................................................... 35
                                                      6.2.1      Introduction ........................................................................................................................... 35
                                                      6.2.2      OTC Category Analysis........................................................................................................... 42
                                                      6.2.3      Key Growth Drivers and Restraints ........................................................................................ 43
                                                      6.2.4      OTC Sales Forecast to 2018 ................................................................................................... 44
                                                      6.2.5      Recent Developments ............................................................................................................ 45
                                                      6.2.6      Outlook .................................................................................................................................. 45
                                                  6.3      Russia ............................................................................................................................................ 46
                                                      6.3.1      Introduction ........................................................................................................................... 46
                                                      6.3.2      OTC Category Analysis........................................................................................................... 52
                                                      6.3.3      Key Growth Drivers and Restraints ........................................................................................ 53
                                                      6.3.4      OTC Sales Forecast to 2018 ................................................................................................... 54


  © GBI Research. This is a licensed product and is not to be photocopied                                                                                           GBIHC253MR / Published NOV 2012
                                                                                                                                                                                             Page 5
Table of Contents




                                                    6.3.5     Recent Developments ............................................................................................................ 55
                                                    6.3.6     Outlook .................................................................................................................................. 55
                                                6.4      Brazil .............................................................................................................................................. 56
                                                    6.4.1     Introduction ........................................................................................................................... 56
                                                    6.4.2     OTC Category Analysis........................................................................................................... 62
                                                    6.4.3     Key Growth Drivers and Restraints ........................................................................................ 63
                                                    6.4.4     OTC Sales Forecast to 2018 ................................................................................................... 64
                                                    6.4.5     Recent Developments ............................................................................................................ 64
                                                    6.4.6     Outlook .................................................................................................................................. 65
                                                6.5      Mexico ........................................................................................................................................... 65
                                                    6.5.1     Introduction ........................................................................................................................... 65
                                                    6.5.2     OTC Category Analysis........................................................................................................... 71
                                                    6.5.3     Key Growth Drivers and Restraints ........................................................................................ 72
                                                    6.5.4     OTC Sales Forecast to 2018 ................................................................................................... 73
                                                    6.5.5     Recent Developments ............................................................................................................ 74
                                                    6.5.6     Outlook .................................................................................................................................. 74
                                                6.6      Turkey ............................................................................................................................................ 75
                                                    6.6.1     Introduction ........................................................................................................................... 75
                                                    6.6.2     OTC Category Analysis........................................................................................................... 81
                                                    6.6.3     Key Growth Drivers and Restraints ........................................................................................ 82
                                                    6.6.4     OTC Sales Forecast to 2018 ................................................................................................... 83
                                                    6.6.5     Recent Developments ............................................................................................................ 84
                                                    6.6.6     Outlook .................................................................................................................................. 84
                                                6.7      Indonesia ....................................................................................................................................... 85
                                                    6.7.1     Introduction ........................................................................................................................... 85
                                                    6.7.2     OTC Category Analysis........................................................................................................... 92
                                                    6.7.3     Key Growth Drivers and Restraints ........................................................................................ 93
                                                    6.7.4     OTC Sales Forecast to 2018 ................................................................................................... 94
                                                    6.7.5     Recent Developments ............................................................................................................ 95
                                                    6.7.6     Outlook .................................................................................................................................. 95
                                              7 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Takeaway ................................ 96
                                              8 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Appendix ................................. 98
                                                8.1      Abbreviations ................................................................................................................................ 98
                                                8.2      Sources .......................................................................................................................................... 98
                                                8.3      Research Methodology ............................................................................................................... 100
                                                    8.3.1     Coverage ............................................................................................................................. 100
                                                    8.3.2     Secondary Research ............................................................................................................ 100
                                                    8.3.3     Primary Research ................................................................................................................ 101
                                                    8.3.4     Therapeutic Landscape........................................................................................................ 101
                                                    8.3.5     Expert Panel Validation ....................................................................................................... 104
                                                8.4      Contact Us ................................................................................................................................... 104
                                                8.5      Disclaimer .................................................................................................................................... 104




  © GBI Research. This is a licensed product and is not to be photocopied                                                                                          GBIHC253MR / Published NOV 2012
                                                                                                                                                                                            Page 6
Table of Contents




                                              1.1       List of Tables
                                              Table 1:       OTC Market, Seven Emerging Markets, Sales ($bn), 2011-2018 .................................................. 18
                                              Table 2:       OTC Market, Seven Emerging Markets, Drivers and Restraints.................................................... 20
                                              Table 3:       OTC Market, Drivers and Restraints, China .................................................................................. 32
                                              Table 4:       OTC Market, China, Sales ($bn), 2011-2018 ................................................................................. 33
                                              Table 5:       OTC Market, Drivers and Restraints, India ................................................................................... 43
                                              Table 6:       OTC Market, India, Sales ($bn), 2011-2018 .................................................................................. 44
                                              Table 7:       OTC Market, Drivers and Restraints, Russia ................................................................................. 53
                                              Table 8:       OTC Market, Russia, Sales ($bn), 2011-2018 ................................................................................ 54
                                              Table 9:       OTC Market, Drivers and Restraints, Brazil................................................................................... 63
                                              Table 10:      OTC Market, Brazil, Sales ($bn), 2011-2018 ................................................................................. 64
                                              Table 11:      OTC Market, Drivers and Restraints, Mexico ................................................................................ 72
                                              Table 12:      OTC Market, Mexico, Sales ($bn), 2011-2018 .............................................................................. 73
                                              Table 13:      OTC Market, Drivers and Restraints, Turkey ................................................................................ 82
                                              Table 14:      OTC Market, Turkey, Sales ($bn), 2011-2018 ............................................................................... 83
                                              Table 15:      OTC Market, Drivers and Restraints, Indonesia ............................................................................ 93
                                              Table 16:      OTC Market, Indonesia, Sales ($bn), 2011-2018 .......................................................................... 94


                                              1.2       List of Figures
                                              Figure 1: OTC Market, Seven Emerging Markets, Sales by Markets ($bn), 2011-2018 ............................... 18
                                              Figure 2: OTC Market, Seven Emerging Markets, Annual Growth Rates (%), 2011-2018............................ 19
                                              Figure 3: Population Pyramid by Age Class, China, 2010............................................................................. 23
                                              Figure 4: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 ..................................... 24
                                              Figure 5: Main Causes of Death, China, Ages 0-14, Both Sexes (%), 2008 ................................................... 25
                                              Figure 6: Main Causes of Death, China, Ages 15-59, Both Sexes (%), 2008 ................................................. 26
                                              Figure 7: Main Causes of Death, China, Ages >60, Both Sexes (%), 2008 .................................................... 27
                                              Figure 8: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 ................. 28
                                              Figure 9: OTC Market, China, by Category (Including TCM), Sales (%), 2011 .............................................. 30
                                              Figure 10: OTC Market, China, by Category (Excluding TCM), Sales (%), 2011.............................................. 30
                                              Figure 11: OTC Market, China, Sales ($bn), 2011-2018 ................................................................................. 33
                                              Figure 12: Population Pyramid, India, 2010 .................................................................................................. 35
                                              Figure 13: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 ..................................... 36
                                              Figure 14: Main Causes of Death, India, Ages 0-14, Both Sexes (%), 2008 .................................................... 37
                                              Figure 15: Main Causes of Death, India, Ages 15-59, Both Sexes (%), 2008 .................................................. 38
                                              Figure 16: Main Causes of Death, India, Ages >60, Both Sexes (%), 2008 ..................................................... 39
                                              Figure 17: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 ................. 40
                                              Figure 18: OTC Market, India, by Category, Sales (%),2011 .......................................................................... 42
                                              Figure 19: OTC Market, India, Sales ($bn), 2011-2018 .................................................................................. 44
                                              Figure 20: Population Pyramid, Russia, 2010 ................................................................................................ 46
                                              Figure 21: Populations > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018.................................... 47
                                              Figure 22: Main Causes of Death, Russia, Ages 0-14, Both Sexes (%), 2008.................................................. 48
                                              Figure 23: Main Causes of Death, Russia, Ages 15-59, Both Sexes (%), 2008................................................ 49
                                              Figure 24: Main Causes of Death, Russia, Age >60, Both Sexes (%), 2008 .................................................... 50
                                              Figure 25: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 ................. 51
                                              Figure 26: OTC Market, Russia, by Category, Sales (%), 2011 ....................................................................... 52
                                              Figure 27: OTC Market, Russia, Sales ($bn), 2011-2018 ................................................................................ 54
                                              Figure 28: Population Pyramid, Brazil, 2010.................................................................................................... 56
                                              Figure 29: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 ..................................... 57
                                              Figure 30: Main Causes of Death, Brazil, Ages 0-14, Both Sexes (%), 2008 ................................................... 58
                                              Figure 31: Main Causes of Death, Brazil, Ages 15-59, Both Sexes (%), 2008 ................................................. 59
                                              Figure 32: Main Causes of Death, Brazil, Ages >60, Both Sexes (%), 2008 .................................................... 60
                                              Figure 33: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 ................. 61
                                              Figure 34: OTC Market, Brazil, by Category, Sales (%), 2011 ........................................................................... 62
                                              Figure 35: OTC Market, Brazil, Sales ($bn), 2011-2018 ................................................................................. 64
                                              Figure 36: Population Pyramid, Mexico, 2010............................................................................................... 65

  © GBI Research. This is a licensed product and is not to be photocopied                                                                              GBIHC253MR / Published NOV 2012
                                                                                                                                                                                Page 7
Table of Contents




                                              Figure 37:   Populations > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018.................................... 66
                                              Figure 38:   Main Causes of Death, Mexico, Ages 0-14, Both Sexes (%), 2008 ................................................ 67
                                              Figure 39:   Main Causes of Death, Mexico, Ages 15-59, Both Sexes (%), 2008 .............................................. 68
                                              Figure 40:   Main Causes of Death, Mexico, Ages >60, Both Sexes (%), 2008 ................................................. 69
                                              Figure 41:   Overweight and Obese Population, Seven Emerging Markets, C
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:16
posted:1/23/2013
language:English
pages:104
Description: GBI Research, the leading business intelligence provider, has released its latest research, “OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth”, which provides insights into the up-and-coming trends of the Over the Counter (OTC) pharmaceutical market by analyzing the trends in population health, healthcare and self-care in seven emerging markets: China, India, Russia, Brazil, Mexico, Indonesia and Turkey.
BUY THIS DOCUMENT NOW PRICE: $3500 100% MONEY BACK GUARANTEED
PARTNER GBI Research
GBI Research is a market-leading provider of business intelligence reports. GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders’ insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs. Headquartered in the UK, the company has branches in the US and Asia, and provides world class client support and service.